97 related articles for article (PubMed ID: 29556623)
1. Expression of E-cadherin in lung carcinoma, other than those with small cells (NSCLC).
Grigoraş ML; Arghirescu TS; Folescu R; Talpoş IC; Gîndac CM; Zamfir CL; Cornianu M; Anghel MD; Levai CM
Rom J Morphol Embryol; 2017; 58(4):1317-1325. PubMed ID: 29556623
[TBL] [Abstract][Full Text] [Related]
2. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.
Sulzer MA; Leers MP; van Noord JA; Bollen EC; Theunissen PH
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1319-23. PubMed ID: 9563756
[TBL] [Abstract][Full Text] [Related]
3. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
[TBL] [Abstract][Full Text] [Related]
4. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.
Kase S; Sugio K; Yamazaki K; Okamoto T; Yano T; Sugimachi K
Clin Cancer Res; 2000 Dec; 6(12):4789-96. PubMed ID: 11156236
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.
Stefanou D; Goussia AC; Arkoumani E; Agnantis NJ
Anticancer Res; 2003; 23(6C):4715-20. PubMed ID: 14981918
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.
Kimura K; Endo Y; Yonemura Y; Heizmann CW; Schafer BW; Watanabe Y; Sasaki T
Int J Oncol; 2000 Jun; 16(6):1125-31. PubMed ID: 10811984
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer.
Liu D; Huang C; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Yokomise H
Ann Thorac Surg; 2001 Mar; 71(3):949-54; discussion 954-5. PubMed ID: 11269479
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
12. The role of E-cadherin expression in non-small cell lung cancer.
Lim SC; Jang IG; Kim YC; Park KO
J Korean Med Sci; 2000 Oct; 15(5):501-6. PubMed ID: 11068984
[TBL] [Abstract][Full Text] [Related]
13. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients.
Zhao JQ; Sun FJ; Liu SS; Yang J; Wu YQ; Li GS; Chen QY; Wang JX
Asian Pac J Cancer Prev; 2013; 14(2):639-43. PubMed ID: 23621211
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
[TBL] [Abstract][Full Text] [Related]
15. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.
Fan C; Zhao Y; Liu D; Zhang X; Wang E
Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer.
Jin S; Zhu W; Shi Q; Zhang Z; Guo R
Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515
[TBL] [Abstract][Full Text] [Related]
17. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells.
Xu HT; Li QC; Zhang YX; Zhao Y; Liu Y; Yang ZQ; Wang EH
Folia Histochem Cytobiol; 2008; 46(3):315-21. PubMed ID: 19056535
[TBL] [Abstract][Full Text] [Related]
18. Defected expression of E-cadherin in non-small cell lung cancer.
Fei Q; Zhang H; Chen X; Wang JC; Zhang R; Xu W; Zhang Z; Zou W; Zhang K; Qi Q; Wang M; Tao S; Luo Z
Lung Cancer; 2002 Aug; 37(2):147-52. PubMed ID: 12140137
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM
Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460
[TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
